FF
GSK icon

Fluent Financial’s GSK GSK Stock Holding History

Fluent Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-75,602
Closed -$3.56M – 58
2020
Q3 		$3.56M Buy
75,602
+2,927
+4% +$147K 2.14% 15
2020
Q2 		$3.71M Buy
72,675
+6,120
+9% +$314K 2.27% 16
2020
Q1 		$3.15M Buy
66,555
+17,112
+35% +$913K 2.28% 14
2019
Q4 		$2.9M Sell
49,443
-4,219
-8% -$235K 1.78% 19
2019
Q3 		$2.86M Sell
53,662
-1,072
-2% -$55.1K 1.94% 12
2019
Q2 		$2.74M Buy
54,734
+8,150
+17% +$409K 2.04% 15
2019
Q1 		$2.43M Buy
46,584
+895
+2% +$44.7K 2% 16
2018
Q4 		$2.18M Buy
45,689
+5,246
+13% +$258K 1.47% 21
2018
Q3 		$2.03M Buy
40,443
+1,124
+3% +$57.1K 1.35% 26
2018
Q2 		$1.98M Sell
39,319
-2,533
-6% -$128K 1.31% 24
2018
Q1 		$2.04M Buy
41,852
+10,783
+35% +$502K 1.42% 22
2017
Q4 		$1.45M Buy
+31,069
New +$1.44M 1.01% 32

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Fluent Financial's GSK Position: Q4 2020 in Review

Fluent Financial sold out of GSK (GSK) in Q4 2020, closing a stake of 75,602 shares — an estimated $3.56M sold.

Fluent Financial first reported a position in GSK in Q4 2017 and held it in 12 quarters. The position peaked at $3.71M in Q2 2020. 819 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • Fluent Financial reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • Fluent Financial sold 75,602 GSK shares in Q4 2020, an estimated $3.56M.
  • Fluent Financial first reported a position in GSK in Q4 2017 and held it in 12 quarters.
  • Fluent Financial's GSK position peaked at $3.71M in Q2 2020.
  • 819 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Fluent Financial's 13F filing for Q4 2020, filed 22 Jan 2021.